Artículos del autor

solaci

Institutional News

Watch Again Tricuspid Valve: New Options for Structural Percutaneous Treatment

Enjoy once again a new SOLACI Sessions event: “Tricuspid Valve: New Options for Structural Percutaneous Treatment” on...
solaci -
Chronic Ischemic cardiopathy

A Meta Analysis of Distal Transradial Access vs. Conventional Transradial

Transradial access is currently the preferred access for diagnostic and therapeutic interventions. However, about 7% of patients...
solaci -
Coronary disease

Do Symptoms and Quality of Life Differ between Focal and Diffuse Coronary Artery Disease?

Changes in fractional flow reserve (FFR) values after percutaneous coronary intervention (PCI) are associated with improvement in...
solaci -
Other

Pulmonary Artery Denervation: Valid Alternative for Pulmonary Arterial Hypertension Grade 1?

Pulmonary vessels are densely innervated by sympathetic, parasympathetic, and sensitive fibers.  According to the World Health Organization (WHO)...
solaci -
Acute coronary syndromes

How Do We Manage Antiaggregation in BARC I Bleeding after AMI?

Dual antiplatelet therapy (DAPT) after acute myocardial infarction (AMI) has been shown useful to reduce thrombotic events,...
solaci -
Structural heart disease

Mitral Trial: 2-Year Followup

At present, an important group of patients with mitral valve disease are at high surgical risk, especially...
solaci -
Chronic Ischemic cardiopathy

P2Y12 Inhibitor Monotherapy vs Aspirin: Results of a Network Meta-Analysis

Revascularization and antiaggregation guidelines have typically recommended aspirin (AAS) as first choice for secondary prevention of cardiovascular...
solaci -
Structural heart disease

Valve-in-Valve Shows Good Evolution after 2 Years

The degeneration of bioprostheses in aortic position occurs at approximately after 10 to 15 years. In this...
solaci -